BIIB059

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	16

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 10 of 16 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-006378-22-NL (EUCTR)	11/01/2023	05/10/2022	A Study to Evaluate the Continuous Safety and Efficacy of BIIB059in Adults with Active Systemic Lupu ...	A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safe ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: BIIB059	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	864	Phase 3	Israel;Chile;Colombia;Italy;France;Puerto Rico;Peru;Australia;Netherlands;China;Korea, Republic of;C ...
2	NCT05352919 (ClinicalTrials.gov)	June 10, 2022	25/4/2022	A Study to Evaluate the Continuous Safety and Efficacy of BIIB059(Litifilimab) in Adults With Active ...	A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safe ...	Systemic Lupus Erythematosus (SLE)	Drug: BIIB059 (litifilimab);Drug: Placebo	Biogen	NULL	Recruiting	18 Years	N/A	All	864	Phase 3	United States;Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Czechia;France ...
3	EUCTR2020-005776-35-DE (EUCTR)	20/04/2022	01/10/2021	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	Serbia;United States;Czechia;Israel;Colombia;United Kingdom;Italy;Hungary;Canada;Argentina;Belgium;R ...
4	EUCTR2020-005775-12-FR (EUCTR)	01/04/2022	26/08/2021	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	United States;Philippines;Taiwan;Greece;Spain;Chile;Russian Federation;France;Mexico;Brazil;Poland;A ...
5	EUCTR2020-005776-35-RO (EUCTR)	10/02/2022	29/04/2022	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	Serbia;United States;Czechia;Israel;Colombia;Italy;United Kingdom;Hungary;Canada;Argentina;Belgium;R ...
6	EUCTR2020-005776-35-NL (EUCTR)	24/12/2021	13/09/2021	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	Serbia;United States;Czechia;Israel;Colombia;United Kingdom;Italy;Hungary;Canada;Argentina;Belgium;R ...
7	EUCTR2020-005776-35-HU (EUCTR)	10/11/2021	08/10/2021	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	Serbia;United States;Czechia;Israel;Colombia;United Kingdom;Italy;Hungary;Canada;Argentina;Belgium;R ...
8	EUCTR2020-005775-12-GR (EUCTR)	02/11/2021	13/09/2021	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	United States;Philippines;Taiwan;Greece;Spain;Chile;Russian Federation;France;Mexico;Poland;Brazil;A ...
9	EUCTR2020-005776-35-IT (EUCTR)	02/11/2021	27/01/2022	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: [BIIB059] INN or Proposed INN: HA 1A ANTICORPO MONOCLONALE ...	BIOGEN IDEC RESEARCH LIMITED	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	United States;Czechia;Israel;Colombia;United Kingdom;Italy;Hungary;Canada;Argentina;Belgium;Romania; ...
10	EUCTR2020-005775-12-ES (EUCTR)	05/10/2021	08/07/2021	A Study to Evaluate the Efficacy and Safety of BIIB059in Adult Participants With Active Systemic Lup ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	United States;Philippines;Taiwan;Greece;Spain;Chile;Russian Federation;France;Mexico;Poland;Brazil;A ...

First Previous1 2Next Last